Company Profile
Re-vana Therapeutics Ltd
ni638333•Private Limited With Share Capital
Get Full Access
09/05/2016
10 years
5
12
72110
moderate risk
Company Overview
Registration, classification & business activity
Re-vana Therapeutics Ltd (ni638333) is a private limited with share capital incorporated on 09/05/2016 (10 years old) and registered in belfast, BT39DT. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Re-vana is developing photocrosslinked technologies for delivery of a wide range of therapeutics that may dramatically extend the time between intravitreal, topical or other injectable routes of administrations to the eye. in addition, we can reduce or potentially eliminate the need for topical drug...
Financial Overview
£7.05M
£4.38M
£2.67M
£2.50M
£5.43M
Key Metrics
12
Employees
5
Directors
4
Shareholders
Board of Directors
Innovate Grants
This company received a grant of £191752.0 for Development Of A Novel Implantable Biodegradable Device For Sustained Ocular Drug Delivery. The project started on 01/10/2019 and ended on 31/03/2021.
This company received a grant of £170398.0 for Co-Development Of A Novel Injection And Crosslinking Device For Delivering Long-Acting Biologic Formulations For Ocular Drug Delivery. The project started on 01/06/2022 and ended on 30/11/2023.
+1 more grants available
Import / Export
Risk Assessment
moderate risk
International Score
Future Factor
excellent
Performance Rating